This document is a USPTO patent application (US20260083730A1) for a method of treating eye disorders, specifically presbyopia, glaucoma, or halos and glare, by administering a liquid composition containing dapiprazole or its pharmaceutically acceptable salt. The application was filed by Baradaina LLC and lists John C. MICHAEL as the inventor.

This is a patent application, not a rule or guidance, and therefore does not impose direct compliance obligations on regulated entities. However, it is relevant for pharmaceutical companies and drug manufacturers involved in the research, development, and commercialization of treatments for eye disorders. Legal and R&D departments should be aware of this filing as it pertains to intellectual property in the ophthalmology space.